Search

everythinglearnresearchcommunity

for

Search:↓

The Fatty Liver Index (FLI) may not be enough to rule out non-alcoholic fatty liver disease in lean women with polycystic ovary syndrome.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

MicroRNAs could be key biomarkers and therapeutic targets for PCOS.

The study found genetic differences related to hair development that may explain hair loss in a patient with Trichorhinophalangeal syndrome type I.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

Karunjchirakam Chooranam significantly improved symptoms in most PCOS cases.

Most non-medical students at Tarumanagara University have good knowledge and attitudes about PCOS.

Polycystic Ovary Syndrome (PCOS) is common in women with conditions like anovulation, hirsutism, hair loss, and type 2 diabetes, and it can lead to health risks like heart disease, obesity, insulin resistance, and depression. Non-Classic Congenital Adrenal Hyperplasia (NC-CAH) is also discussed.

Most women with polycystic ovary syndrome (PCOS) have menstrual issues, infertility, acne, and excessive body hair, with the most common type being the non-androgenic phenotype.

Netherton Syndrome is a non-treatable genetic disorder in children causing skin, hair, and allergy issues.

Obese women with PCOS have lower zinc levels than non-obese ones.

Autoimmune Polyendocrine Syndromes involve specific combinations of endocrine and non-endocrine autoimmune diseases.

Cronkhite-Canada syndrome is a rare, non-inherited condition causing various symptoms like polyps, hair loss, and weight loss.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

New treatments for PCOS show promise, including both medication and non-medication options.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

The Polish medical societies have redefined metabolic syndrome and recommend lifestyle changes, certain medications, and possibly bariatric surgery for treatment. They also discuss managing related health conditions.

Managing oxidative stress might help treat low testosterone and related chronic diseases in aging men.

Cantú syndrome may be linked to pituitary adenomas.

Gastric bypass surgery improved a woman's hormonal disorder without the need for medication.

Losing weight and eating better are key to managing metabolic syndrome and its related conditions.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Women with PCOS have more severe liver disease.

PCOS is often caused by hormonal imbalances that can lead to various health issues and may indicate a risk for future metabolic and cardiovascular problems.

Obese women with PCOS are more likely to have fatty liver disease.

Mutations in certain receptors can cause diseases and offer new treatment options.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Four new cases of Bachmann-Bupp syndrome suggest potential for targeted treatment.